• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Scopus
  4. Data sharing in neurodegenerative disease research: challenges and learnings from the innovative medicines initiative public-private partnership model
 
  • Details
  • Full
Options
2023
Review
Title

Data sharing in neurodegenerative disease research: challenges and learnings from the innovative medicines initiative public-private partnership model

Abstract
Efficient data sharing is hampered by an array of organizational, ethical, behavioral, and technical challenges, slowing research progress and reducing the utility of data generated by clinical research studies on neurodegenerative diseases. There is a particular need to address differences between public and private sector environments for research and data sharing, which have varying standards, expectations, motivations, and interests. The Neuronet data sharing Working Group was set up to understand the existing barriers to data sharing in public-private partnership projects, and to provide guidance to overcome these barriers, by convening data sharing experts from diverse projects in the IMI neurodegeneration portfolio. In this policy and practice review, we outline the challenges and learnings of the WG, providing the neurodegeneration community with examples of good practices and recommendations on how to overcome obstacles to data sharing. These obstacles span organizational issues linked to the unique structure of cross-sectoral, collaborative research initiatives, to technical issues that affect the storage, structure and annotations of individual datasets. We also identify sociotechnical hurdles, such as academic recognition and reward systems that disincentivise data sharing, and legal challenges linked to heightened perceptions of data privacy risk, compounded by a lack of clear guidance on GDPR compliance mechanisms for public-private research. Focusing on real-world, neuroimaging and digital biomarker data, we highlight particular challenges and learnings for data sharing, such as data management planning, development of ethical codes of conduct, and harmonization of protocols and curation processes. Cross-cutting solutions and enablers include the principles of transparency, standardization and co-design – from open, accessible metadata catalogs that enhance findability of data, to measures that increase visibility and trust in data reuse.
Author(s)
Bradshaw, Angela C.
Alzheimer Europe
Hughes, Nigel
Janssen Pharmaceutica, Headquarters
Valléz García, David Vollez
Amsterdam UMC - University of Amsterdam
Chokoshvili, Davit
University of Luxembourg
Owens, Andrew P.
King's College London
Hansen, Clint C.
Universitätsklinikum Schleswig-Holstein Campus Kiel
Emmert, Kirsten Nele
Universitätsklinikum Schleswig-Holstein Campus Kiel
Maetzler, Walter
Universitätsklinikum Schleswig-Holstein Campus Kiel
Killin, Lewis O.J.
Synapse Research Management Partners
Barnes, Rodrigo
Aridhia Informatics Limited
Brookes, Anthony J.
College of Life Sciences
Visser, Pieter Jelle
Universiteit Maastricht
Hofmann-Apitius, Martin  
Fraunhofer-Institut für Algorithmen und Wissenschaftliches Rechnen SCAI  
Díaz, Carlos
Synapse Research Management Partners
Steukers, Lennert
Janssen Pharmaceutica, Headquarters
Journal
Frontiers in Neurology
Funder
European Federation of Pharmaceutical Industries and Associations
Open Access
DOI
10.3389/fneur.2023.1187095
Additional link
Full text
Language
English
Fraunhofer-Institut für Algorithmen und Wissenschaftliches Rechnen SCAI  
Keyword(s)
  • data sharing

  • digital endpoint

  • GDPR

  • innovative medicines initiative

  • neurodegenerative disease

  • real world data

  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024